Havn Life Sciences Stock Today
| HAVLF Stock | USD 0.0005 0.00 0.00% |
PerformanceOK
| Odds Of DistressHigh
|
HAVN Life is trading at 5.0E-4 as of the 20th of March 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 5.0E-4. HAVN Life has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The company was incorporated in 2020 and is headquartered in Richmond, Canada. Havn Life operates under Biotechnology classification in the United States and is traded on OTC Exchange.. The company has 8.47 M outstanding shares. More on HAVN Life Sciences
Moving together with HAVN Pink Sheet
Moving against HAVN Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
HAVN Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
HAVN Life Sciences [HAVLF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 415.27 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HAVN Life's market, we take the total number of its shares issued and multiply it by HAVN Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. HAVN Life Sciences classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 8.47 M outstanding shares.
HAVN Life Sciences has accumulated about 112.42 K in cash with (7.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check HAVN Life Probability Of Bankruptcy
Ownership AllocationRoughly 97.23 (percent) of HAVN Life outstanding shares are held by general public with 2.77 % owned by insiders and only 0.0 pct. by outside corporations.
Check HAVN Ownership Details
HAVN Life Sciences Risk Profiles
| Mean Deviation | 26.96 | |||
| Standard Deviation | 112.33 | |||
| Variance | 12617.86 | |||
| Risk Adjusted Performance | 0.0906 |
HAVN Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in HAVN Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Other Information on Investing in HAVN Pink Sheet
HAVN Life financial ratios help investors to determine whether HAVN Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HAVN with respect to the benefits of owning HAVN Life security.